DIP expression in hepatocellular carcinoma and its clinical significance
Author:
Affiliation:

Clc Number:

R735.7

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective: To investigate the death inducing protein (DIP) expression in hepatocellular carcinoma (HCC) and its relations with the clinicopathological features of HCC. Methods: The mRNA and protein expressions of DIP in 40 HCC and their adjacent normal tissues were measured by RT-PCT and immunohistochemical staining respectively, and the relations of DIP protein expression with the clinicopathological features of HCC were analyzed. The DIP mRNA expressions in normal human liver cell line (LO2) and various human HCC cell lines (HepG2, Hep3B and SMMC-7721) were determined by RT-PCR method. Results: Both mRNA and protein expressions of DIP in HCC tissues were significantly higher than those in their adjacent tissues (both P<0.05), and high DIP expression was associated with larger tumor size, high Edmonson-Steiner’s classification and advanced TNM stage (r=0.419, 0.414, 0.531; all P<0.05). The DIP mRNA expressions in all HCC cell lines (HepG2, Hep3B, and SMMC-7721) were significantly higher than that in LO2 (all P<0.05). Conclusion: The DIP expression is up-regulated in HCC tissue, and the high DIP expression is associated with the unfavorable clinicopathological profiles of HCC.

    Reference
    Related
    Cited by
Get Citation

CHEN Cui, LI Jie, ZHENG Jun. DIP expression in hepatocellular carcinoma and its clinical significance[J]. Chin J Gen Surg,2013,22(7):900-904.
DOI:10.7659/j. issn.1005-6947.2013.07.017

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 24,2012
  • Revised:April 30,2013
  • Adopted:
  • Online: July 15,2013
  • Published: